sorbitol has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marfè, G | 1 |
| Morgante, E | 1 |
| Di Stefano, C | 1 |
| Di Renzo, L | 1 |
| De Martino, L | 1 |
| Iovane, G | 1 |
| Russo, MA | 1 |
| Sinibaldi-Salimei, P | 1 |
1 other study available for sorbitol and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Sorbitol-induced apoptosis of human leukemia is mediated by caspase activation and cytochrome c release.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cytochromes c; DNA; DNA Fragmentation; Dose-Response Re | 2008 |